摘要
目的为研究FQPCR技术在妇女UU感染疗效监测中的应用，确定合适的治疗后复诊间隔时间。方法FQPCR方法用于定量检测2002年-2010年间生殖中心647例不育症妇女宫颈分泌物中uuDNA，并对UUDNA阳性患者治疗1～3个疗程转阴率与治疗后复诊间隔时间相关性进行了分析。结果治疗后9～15天复查转阴率（386／421，91．69％）高于治疗后≤8天（26／32，81．25％）（x2=3．94，P=0．047）和治疗后≥16天（164／194，84．54%）（x2=7．18，P=0．0074）复诊者。转阴率与复诊间隔时间正相关（r=0．347，P=7．9E-0．5）。结论最适复诊间隔时间为两个疗程后（9-15天）。
Objective To study the use of FQ-PCR in inspecting therapy for the women infected by UU. Methods FQ-PCR was used to detect quantitatively UU DNA in the sample of cervical secretion of the 647 female cases from the Department of Procreation from 2002 to 2010. After 1-3 period of treatment for the patients with UU DNA positive, the relativity between the negative rate and the time interval of further consultation with a doctor was analysed. Results After therapy for 9-15 days, the negative rate （386/421,91.69%） was highter than 48 days （26/32,81.25%） （X2 = 3.94, P=0. 047） and ≥16 days （164/194,84.54 %）（X2 = 7.18, P= 0. 0074）. The negative rate increased with the time interval of further consultation with a doctor （r=0. 347, P=7.9E--0. 5）. Conclusion The optimal time interval of further consultation with a doctor was two period of treatment （9-15 days）.
出处
《现代检验医学杂志》
CAS
2012年第4期84-85,共2页
Journal of Modern Laboratory Medicine
